Comprehensive analysis of tumoral DNA content reveals clonal ploidy heterogeneity as a marker with prognostic significance in locoregional neuroblastoma

Genes Chromosomes and Cancer

Volumn 46, Issue 4, 2007, Pages 385-396

  Mora, Jaume ^a   Lavarino, Cinzia ^a   Alaminos, Miguel ^b   Cheung, Nai Kong V ^c   Ríos, José ^d   De Torres, Carmen ^a   Illei, Peter ^c   Juan, Gloria ^c   Gerald, William L ^c  

^a HOSPITAL SANT JOAN DE DÉU   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; TUMOR MARKER;

ANEUPLOIDY; ARTICLE; CANCER STAGING; CONTROLLED STUDY; DIPLOIDY; DNA CONTENT; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; HUMAN; HUMAN TISSUE; KARYOTYPING; LASER SCANNING CYTOMETRY; MULTIVARIATE ANALYSIS; NEUROBLASTOMA; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; TRIPLOIDY; TUMOR GROWTH;

BIOLOGICAL MARKERS; CYTOGENETIC ANALYSIS; DNA; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; NEUROBLASTOMA; PROGNOSIS;

EID: 33947098855     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20421     Document Type: Article

References (43)

1. Barlogie B, Gohde W, Johnston DA, Smallwood L, Schumann J, Drewinko B, Freireich EJ. 1978. Determination of ploidy and proliferative characteristics of human solid tumors by pulse cytophotometry. Cancer Res 38:3333-3339.
2. Barlogie B, Hittelman W, Spitzer G, Trujilo JM, Hart JS, Smallwood L, Drewinko B. 1977. Correlation of DNA distribution abnormalities with cytogenetic findings in human adult leukemia and lymphoma. Cancer Res 37:4400-4407.
3. Barlogie B, Raber MN, Schumann J, Johnson TS, Drewinko B, Swartzendruber DE, Gohde W, Andreeff M, Freireich EJ. 1983. Flow cytometry in clinical cancer research. Cancer Res 43:3982-3997.
4. Bown N, Cotterill S, Lastowska M, O'Neill S, Pearson AD, Plantaz D, Meddeb M, Danglot G, Brinkschmidt C, Christiansen H, Laureys G, Speleman F, Nicholson J, Bernheim A, Betts DR, Vandesompele J, Van Roy N. 1999. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. N Engl J Med 340:1954-1961.
5. Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP, De Bernardi B, Evans AE, Favrot M, Hedborg F, Kaneko M, Kemshead J, Lampert F, Lee REJ, Look T, Pearson ADJ, Philip T, Roald B, Sawada T, Seeger RC, Tsuchida Y, Voute PA. 1993. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11:1466-1477.
6. Cawkwell L, Bell SM, Lewis FA, Dixon MF, Taylor GR, Quirke P. 1993. Rapid detection of allelic loss in colorectal tumors using microsatellites and fluorescent detection technology. Br J Cancer 67:1262-1267.
7. Cheung NK, Saarinen UM, Neely JE, Landmeier B, Donovan D, Coccia PF. 1985. Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells. Cancer Res 45:2642-2649.
8. Christiansen H, Lampert F. 1988. Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastoma. Br J Cancer 57:121-126.
9. Deptala A, Bedner E, Gorczyca W, Darzynkiewicz Z. 1998. Activation of nuclear factor κB (NF-KB) assayed by laser-scanning cytometry (LSC). Cytometry 33:376-382.
10. Fattorossi A, Battaglia A, Maggiano N, Malinconico P, Andreocci L, Mancuso S, Scambia G. 2000. Laser scanning cytometry can complement the flow cytometric DNA analysis in paraffin-embedded cancer samples: A paradigmatic case. Cytometry 42: 123-125.
11. Grady-Leopardi EF, Schwab M, Ablin AR, Rosenau W. 1986. Detection of N-myc oncogene expression in human neuroblastoma by in situ hybridization and blot analysis: Relationship to clinical outcome. Cancer Res 46:3196-3199.
12. Harnden DG, Klinger HP. 1985. An International System for Human Cytogenetic Nomenclature. Basel, Switzerland: S. Karger AG.
13. Hayashi Y, Kanda N, Inaba T, Hanada R, Nagahara N, Muchi H, Yamamoto K. 1989. Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1. Cancer 63: 126-132.
14. Hedley DW. 1989. Flow cytometry using paraffin-embedded tissue: Five years on. Cytometry 10:229-241.
15. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA. 1983. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 31:1333-1335.
16. Heid CA, Stevens J, Livak KJ, Williams PM. 1996. Real time quantitative PCR. Genome Res 6:986-994.
17. Illei P, Feiner H, Yin H, Chan W, Symmans F, Perle MA. 1998. Interphase cytogenetic study of chromosomes 7, 18 and X in tissue scrapes of proliferative fibrocystic disease and ductal carcinoma in situ of the breast. Breast J 4:252-257.
18. Juan G, Cordon-Cardo C. 2001. Intranuclear compartimentalization of cyclin E during the cell cycle: Disruption of the nucleoplasm-nucleolar shuttling of cyclin E in bladder cancer. Cancer Res 61:1220-1226.
19. Juan G, Darzynkiewicz Z. 1998. Cell cycle analysis by flow and laser-scaning cytometry. In: Celis JE, editor. Cell Biology. A Laboratory Handbook. San Diego: Academic Press, pp. 255-268.
20. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D. 1992. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258: 818-821.
21. Kamentsky LA. 2001. Laser scanning cytometry. Methods Cell Biol 63:51-87.
22. Kamentsky LA, Burger DE, Gershman RJ, Kamentsky LD, Luther E. 1997. Slide-based laser scanning cytometry. Acta Cytol 41:123-143.
23. Kaneko Y, Cohn SL. 2000. Ploidy and cytogenetics of neuroblastoma. In: Brodeur GM, Sawada T, Tsuchida Y, Voute PA, editors. Neuroblastoma. Amsterdam: Elsevier, pp. 41-56.
24. Kaneko Y, Kanda N, Maseki N, Sakurai M, Tsuchida Y, Takeda T, Okabe I, Sakurai M. 1987. Different karyotypic patterns in early and advanced stage neuroblastomas. Cancer Res 47:311-318.
25. Kaneko Y, Knudson AG. 2000. Mechanism and relevance of ploidy in neuroblastoma. Genes Chromosomes Cancer 29:89-95.
26. Kilpatrick, SE, Teot LA, Geisinger KR, Martin PL, Shumate DK, Zbieranski N, Russell GB, Fletcher CDM. 1994. Relationship of DNA ploidy to histology and prognosis in rhabdomyosarcoma. Cancer 74:3227-3233.
27. Ladenstein R, Ambros IM, Potschger U, Amann G, Urban C, Fink FM, Schmitt K, Jones R, Slociak M, Schilling F, Ritter J, Berthold F, Gadner H, Ambros PF. 2001. Prognostic significance of DNA di-tetraploidy in neuroblastoma. Med Pediatr Oncol 36:83-92.
28. Look AT, Hayes FA, Nitschke R, McWilliams NB, Green AA. 1984. Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. N Engl J Med 311: 231-235.
29. Look AT, Hayes FA, Shuster JJ, Douglass EC, Castleberry RP, Bowman LC, Smith EI, Brodeur GM. 1991. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: A pediatric oncology group study. J Clin Oncol 9:581-591.
30. Mathew P, Valentine MB, Bowman LC, Rowe ST, Nash MB, Valentine VA, Cohn SL, Castleberry RP, Brodeur GM, Look AT. 2001. Detection of MYCN gene amplification in neuroblastoma by fluorescence in situ hybridization: A pediatric oncology group study. Neoplasia 3:105-109.
31. Mora J, Cheung NKV, Gerald W. 2001a. Genetic heterogeneity and clonal evolution in neuroblastoma. Br J Cancer 85:182-189.
32. Mora J, Cheung NKV, Juan G, Illei P, Cheung I, Chi S, Ladanyi M, Cordon-Cardo C, Gerald WL. 2001b. Schwannian cells of neuroblastoma are derived from a tumoral cell progenitor. Cancer Res 61:6892-6898.
33. Mora J, Gerald W, Chen L, Qin J, Cheung NKV. 2001c. Survival analysis of clinical, pathologic and genetic features in neuroblastoma presenting as local-regional disease. Cancer 91:435-442.
34. Nowell PC. 1974. Chromosome changes and the clonal evolution of cancer. In: German J, editor. Chromosomes and Cancer. New York: Wiley, pp. 267-285.
35. Palitti F, Rizzoni M. 1972. Pattern of DNA segregation in multipolar anatelophases of different ploidy in euploid and aneuploid mammalian cells cultivated in vitro. Genetica 43: 130-147.
36. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D, Collins C, Kuo WL, Chen C, Zhai Y, Dairkee SH, Ljung BM, Gray JW, Albertson DG. 1998. High-resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 20:207-211.
37. Pui CH, Raimondi SC, Dodge RK, Rivera GK, Fuchs LAH, Abromowitch M, Look AT, Furman WL, Crist WM, Williams DL. 1998. Prognostic importance of structural chromosomal abnormalities in children with hyperdiploid (>50 chromosomes) acute lymphoblastic leukemia. Blood 73:1963-1967.
38. Raimondi SC. 2000. Fluorescence in situ hybridization: Molecular probes for diagnosis of pediatric neoplastic diseases. Cancer Invest 18:135-147.
39. Ritterbach J, Hiddemann W, Beck JD, Schrappe M, Janka-Schaub G, Ludwig WD, Harbott J, Lampert F. 1998. Detection of hyperdiploid karyotypes (>50 chromosomes) in childhood acute lymphoblastic leukemia (ALL) using fluorescence in situ hybridization (FISH). Leukemia 2:427-433.
40. Shapiro DN, Valentine MB, Rowe ST, Sinclair AE, Sublett JE, Roberts WM, Look AT. 1993. Detection of N-myc gene amplification by fluorescence in situ hybridization. Diagnostic utility for neuroblastoma. Am J Pathol 142:1339-1346.
41. Spitz R, Betts DR, Simon T, Boensch M, Oestreich J, Niggli FK, Ernestus K, Berthold F, Hero B. 2006. Favorable outcome of triploid neuroblastomas: A contribution to the special oncogenesis of neuroblastoma. Cancer Genet Cytogenet 167:51-56.
42. Taylor CP, Bown NP, McGuckin AG, Lunec J, Malcolm AJ, Pearson AD, Sheer D, for United Kingdom Children's Cancer Study Group. 2000. Fluorescence in situ hybridization techniques for the rapid detection of genetic prognostic factors in neuroblastoma. Br J Cancer 83:40-49.
43. Taylor SR, Blatt J, Costantino JP, Roederer M, Murphy RF. 1988. Flow cytometric DNA analysis of neuroblastoma and ganglioneuroma. A 10-year retrospective study. Cancer 62:749-754.